Vamifeport
Vamifeport (VIT-2763) is a novel orally active inhibitor that targets iron transport proteins and reduces markers of hemolysis in the SCD Townes model.VIT-2763 improves anemia and erythropoiesis, ameliorates vascular inflammation, and can be studied in β-thalassemia.
Product Specifications
CAS Number
2095668-10-1
Stability
≥ 2 years
Purity
>98% (HPLC)
Weight
408.43
Molecular Formula
C21H21FN6O2
Notes
Research use only, not for human use.
Receptor
Ferroptosis
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
ARP32675_P050 100 µL
TSFM antibody - N-terminal region (ARP32675_P050)
Sign In for Pricing
View Details 
MBS6216097-01 0.1 mL
CA1 (Carbonic Anhydrase I, Car1) (MaxLight 550)
Sign In for Pricing
View Details